https://ir.ensysce.com/news/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/ensysce/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.ensysce.com/news/press-releases/detail/224/ensysce-biosciences-to-showcase-a-new-era-in-pain Thu, 20 Aug 26 08:00:00 -0400 https://ir.ensysce.com/news/press-releases/detail/224/ensysce-biosciences-to-showcase-a-new-era-in-pain https://ir.ensysce.com/news/press-releases/detail/223/ensysce-biosciences-reports-second-quarter-2026-financial Thu, 13 Aug 26 16:15:00 -0400 https://ir.ensysce.com/news/press-releases/detail/223/ensysce-biosciences-reports-second-quarter-2026-financial https://ir.ensysce.com/news/press-releases/detail/222/ensysce-biosciences-announces-acquisition-of-cy-biopharma Thu, 06 Aug 26 08:00:00 -0400 https://ir.ensysce.com/news/press-releases/detail/222/ensysce-biosciences-announces-acquisition-of-cy-biopharma https://ir.ensysce.com/news/press-releases/detail/221/ensysce-biosciences-awarded-5-3-million-installment-in Tue, 14 Jul 26 08:00:00 -0400 https://ir.ensysce.com/news/press-releases/detail/221/ensysce-biosciences-awarded-5-3-million-installment-in https://ir.ensysce.com/news/press-releases/detail/220/ensysce-biosciences-enrolls-first-patient-in-final-phase-of Fri, 26 Jun 26 08:00:00 -0400 https://ir.ensysce.com/news/press-releases/detail/220/ensysce-biosciences-enrolls-first-patient-in-final-phase-of https://ir.ensysce.com/news/press-releases/detail/219/ensysce-biosciences-reports-first-quarter-2026-financial Fri, 15 May 26 16:15:00 -0400 https://ir.ensysce.com/news/press-releases/detail/219/ensysce-biosciences-reports-first-quarter-2026-financial https://ir.ensysce.com/news/press-releases/detail/218/ensysce-biosciences-announces-expansion-of-patent Tue, 12 May 26 08:00:00 -0400 https://ir.ensysce.com/news/press-releases/detail/218/ensysce-biosciences-announces-expansion-of-patent https://ir.ensysce.com/news/press-releases/detail/217/ensysce-biosciences-ceo-presents-at-inaugural-clinical-pain Fri, 08 May 26 08:00:00 -0400 https://ir.ensysce.com/news/press-releases/detail/217/ensysce-biosciences-ceo-presents-at-inaugural-clinical-pain https://ir.ensysce.com/news/press-releases/detail/216/ensysce-biosciences-secures-irb-approval-of-final-phase-of Thu, 16 Apr 26 08:00:00 -0400 https://ir.ensysce.com/news/press-releases/detail/216/ensysce-biosciences-secures-irb-approval-of-final-phase-of https://ir.ensysce.com/news/press-releases/detail/215/ensysce-biosciences-secures-second-financing-from-2025 Tue, 07 Apr 26 08:00:00 -0400 https://ir.ensysce.com/news/press-releases/detail/215/ensysce-biosciences-secures-second-financing-from-2025